article thumbnail

Dual GLP-1/GIP Receptor Agonist Shows Decreases in Hemoglobin A1c

Drug Topics

Since their debut, these novel agents have formed an important armamentarium in the management of T2DM,” authors of a review published in Diabetes, Metabolic Syndrome, and Obesity said. GLP-1/GIPs have shown favorable outcomes in diabetes, significantly improving hemoglobin A 1c , which varies by therapeutic agent.

article thumbnail

From ECHELON-3 to Clinical Practice: Newly Approved Brentuximab Vedotin With Lenalidomide and Rituximab for R/R DLBCL

Pharmacy Times

The recent approval of brentuximab vedotin (BV, Adcetris; Seagen Inc) in combination with lenalidomide (Len, Revlimid; Bristol Myers Squibb) and a rituximab (R; BV-R2) product is a pivotal moment in cancer therapeutics and provides an alternative treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Pharmacy Times

Tarlatamab established a new standard for relapsed SCLC, with improved survival and easier administration, enhancing treatment accessibility. Zanubrutinib demonstrated sustained efficacy in CLL with del(17p), emphasizing the importance of BTK inhibitors in high-risk hematologic malignancies.

article thumbnail

A Review of Oral Cephalosporins for Common Outpatient Infections

Pharmacy Times

Because of their ability to cover a wide array of bacteria, low adverse effect profile, and oral availability, cephalosporins are commonly used in the treatment of outpatient infections. Both agents have high bioavailability, achieve high urinary concentrations, are available as suspensions, and can be used in infants.

article thumbnail

Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression

Pharmacy Times

GLP-1 receptor agonists should be considered as second-line agents for older adults with DKD, but potential gastrointestinal side effects must be monitored. SHOW MORE Pharmacists should consider GLP-1 receptor agonists as second-line agents in older adults with DKD when additional glycemic control is needed.

article thumbnail

Self-Care Measures for Prevention and Management of Contact Dermatitis

Pharmacy Times

Pharmacists are key in advising on self-care, prevention, and OTC product selection for mild to moderate contact dermatitis. Pharmacists are key in advising on self-care, prevention, and OTC product selection for mild to moderate contact dermatitis. SHOW MORE Prompt identification and appropriate clinical intervention are critical.

article thumbnail

Educate Patients About Safe Medication Disposal

Pharmacy Times

Image credit: OM | stock.adobe.com Why Proper Disposal Matters Disposing of medications appropriately helps prevent environmental contamination of water and soil. Safe disposal options include DEA Take Back Days, pharmacy kiosks, law enforcement kiosks, mail-back envelopes, and home disposal methods.